Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


28.10.2019

3 Am J Surg
1 Ann Surg Oncol
3 BMC Cancer
1 Br J Cancer
2 Br J Surg
2 Cancer Lett
1 Cancer Res
2 Gastroenterology
1 Gastrointest Endosc
1 Hum Pathol
1 Int J Cancer
1 Int J Colorectal Dis
2 J Surg Oncol
1 Lancet
1 Oncogene
3 Oncol Rep
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. JARRAR A, Sheth R, Tiernan J, Sebikali-Potts A, et al
    Curative intent resection for loco-regionally recurrent colon cancer: Cleveland clinic experience.
    Am J Surg. 2019 Oct 16. pii: S0002-9610(19)31033.
    PubMed     Text format     Abstract available

  2. SERRA-ARACIL X, Gracia R, Mora-Lopez L, Serra-Pla S, et al
    How to deal with rectal lesions more than 15cm from the anal verge through transanal endoscopic microsurgery.
    Am J Surg. 2019;217:53-58.
    PubMed     Text format     Abstract available

  3. LABGAA I, Schwartz M
    Surgery for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: The cornerstone but not the only stone.
    Am J Surg. 2019;217:192.
    PubMed     Text format    


    Ann Surg Oncol

  4. MAKHLOUFI S, Turpin A, El Amrani M, Andre T, et al
    Fong's Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III Trial.
    Ann Surg Oncol. 2019 Oct 22. pii: 10.1245/s10434-019-07976.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. JOHANSEN AFB, Kassentoft CG, Knudsen M, Laursen MB, et al
    Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.
    BMC Cancer. 2019;19:971.
    PubMed     Text format     Abstract available

  6. ADVANI SM, Advani PS, Brown DW, DeSantis SM, et al
    Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.
    BMC Cancer. 2019;19:964.
    PubMed     Text format     Abstract available

  7. LI J, Kong XX, Zhou JJ, Song YM, et al
    Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled study.
    BMC Cancer. 2019;19:988.
    PubMed     Text format     Abstract available


    Br J Cancer

  8. KUWAHARA T, Hazama S, Suzuki N, Yoshida S, et al
    Correction: Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
    Br J Cancer. 2019 Oct 17. pii: 10.1038/s41416-019-0605.
    PubMed     Text format     Abstract available


    Br J Surg

  9. VAN DER POEL MJ, Barkhatov L, Fuks D, Berardi G, et al
    Multicentre propensity score-matched study of laparoscopic versus open repeat liver resection for colorectal liver metastases.
    Br J Surg. 2019;106:783-789.
    PubMed     Text format     Abstract available

  10. WESTBERG K, Palmer G, Hjern F, Holm T, et al
    Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
    Br J Surg. 2019;106:790-798.
    PubMed     Text format     Abstract available


    Cancer Lett

  11. LIU Z, Xie Y, Xiong Y, Liu S, et al
    TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages.
    Cancer Lett. 2019 Oct 17. pii: S0304-3835(19)30517.
    PubMed     Text format     Abstract available

  12. LU YX, Ju HQ, Wang F, Chen LZ, et al
    Corrigendum to "Inhibition of the NF-kappaB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis" [Cancer Lett. 380 (2016) 87-97].
    Cancer Lett. 2019 Oct 14. pii: S0304-3835(19)30492.
    PubMed     Text format    


    Cancer Res

  13. GRIGORYAN H, Schiffman C, Gunter MJ, Naccarati A, et al
    Cys34 Adductomics Links Colorectal Cancer with the Gut Microbiota and Redox Biology.
    Cancer Res. 2019 Oct 22. pii: 0008-5472.CAN-19-1529.
    PubMed     Text format     Abstract available


    Gastroenterology

  14. PENG FB, Kim HS, Agarwal SK
    Abnormal Polypoid Finding During Colonoscopy.
    Gastroenterology. 2019;157:940-941.
    PubMed     Text format    

  15. CROCKETT SD, Nagtegaal ID
    Terminology, Molecular Features, Epidemiology, and Management of Serrated Colorectal Neoplasia.
    Gastroenterology. 2019;157:949-966.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  16. MANKANEY G, Burke CA
    Enhancing the efficacy of colonoscopy in Lynch syndrome: the search for the holy grail continues.
    Gastrointest Endosc. 2019;90:633-635.
    PubMed     Text format    


    Hum Pathol

  17. LIBERA L, Craparotta I, Sahnane N, Chiaravalli AM, et al
    Targeted gene sequencing of Lynch syndrome-related and sporadic endometrial carcinomas.
    Hum Pathol. 2018;81:235-244.
    PubMed     Text format     Abstract available


    Int J Cancer

  18. XU W, Zhou G, Wang H, Liu Y, et al
    Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer.
    Int J Cancer. 2019 Oct 21. doi: 10.1002/ijc.32747.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  19. HANNA K, Zeeshan M, Hamidi M, Pandit V, et al
    Colon cancer in the young: contributing factors and short-term surgical outcomes.
    Int J Colorectal Dis. 2019 Oct 17. pii: 10.1007/s00384-019-03402.
    PubMed     Text format     Abstract available


    J Surg Oncol

  20. GAMBOA AC, Liu Y, Lee RM, Zaidi MY, et al
    A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique.
    J Surg Oncol. 2019;120:932-939.
    PubMed     Text format     Abstract available

  21. ROLFF HC, Christensen IJ, Svendsen LB, Wilhelmsen M, et al
    The concentration of the cleaved suPAR forms in pre- and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study.
    J Surg Oncol. 2019 Oct 23. doi: 10.1002/jso.25733.
    PubMed     Text format     Abstract available


    Lancet

  22. DEKKER E, Tanis PJ, Vleugels JLA, Kasi PM, et al
    Colorectal cancer.
    Lancet. 2019;394:1467-1480.
    PubMed     Text format     Abstract available


    Oncogene

  23. YU CY, Han JX, Zhang J, Jiang P, et al
    A 16q22.1 variant confers susceptibility to colorectal cancer as a distal regulator of ZFP90.
    Oncogene. 2019 Oct 22. pii: 10.1038/s41388-019-1055.
    PubMed     Text format     Abstract available


    Oncol Rep

  24. WU B, Sun D, Ma L, Deng Y, et al
    Exosomes isolated from CAPS1overexpressing colorectal cancer cells promote cell migration.
    Oncol Rep. 2019 Oct 9. doi: 10.3892/or.2019.7361.
    PubMed     Text format     Abstract available

  25. LV Y, Xie B, Bai B, Shan L, et al
    Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of proximal and distal colorectal cancer.
    Oncol Rep. 2019 Oct 14. doi: 10.3892/or.2019.7368.
    PubMed     Text format     Abstract available

  26. ISHIKAWA K, Kawano Y, Arihara Y, Kubo T, et al
    BH3 profiling discriminates the antiapoptotic status of 5fluorouracilresistant colon cancer cells.
    Oncol Rep. 2019 Oct 15. doi: 10.3892/or.2019.7373.
    PubMed     Text format     Abstract available


    PLoS One

  27. SINNER HF, Johnson J, Rychahou PG, Watt DS, et al
    Novel chemotherapeutic agent, FND-4b, activates AMPK and inhibits colorectal cancer cell proliferation.
    PLoS One. 2019;14:e0224253.
    PubMed     Text format     Abstract available

  28. KOJIMA K, Nakamura T, Ooizumi Y, Igarashi K, et al
    Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer.
    PLoS One. 2019;14:e0211108.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: